Introduction:

In the General Teaching Hospital "Octavio de la Concepción y la Pedraja" of Baracoa, Guantánamo province, Cuba, the prescription of Thrombolysis in Myocardial Infarction (TIMI) has not been characterized so far.

Objective:

To charactirize the prescription of thrombolysis in myocardial infarction during the three-year period 2017-2019.

Method:

Of the total number of patients with heart attacks in the above-mentioned period (n=75) a descriptive, retrospective, cross-sectional study was carried out. Variables studied: age, sex, topographic location of the infarction, treatment, clinical evolution, state at discharge and causes of death.

Results:

72.0 % of the patients were men, 37.3 % were 50 and 59 years old. The case fatality rate was 14.7%. Left ventricular infarction was the most common (53.4%) dysfunction. 28.0% of the patients received thrombolytic therapy, because in 68.5% of them, the ischemic was longer than twelve hours. Post-cardiorespiratory moderate ischemic-hypoxic encephalopathy with ventricular fibrillation (54.5%) was the most frequent direct cause of death.

Conclusions:

The patients´ rate treated with systemic coronary thrombolysis was insufficient, mainly due to the fact that they attend medical attention 12 hours after the onset of symptoms.

        · resumen en Español     · texto en Español     · Español ( pdf )